Wyeth-LLC
General
Total Cases148
Active Cases14
Patents2,239
Ratings
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L5
E
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 09/12/24 | NOTICE OF APPEAL to the Federal Circuit of [517] Judgment,, [516] Memorandum and Order . Appeal filed by Wyeth LLC. (Dellinger, Megan) (Entered: 09/12/2024) | |
| 09/12/24 | APPEAL - Credit Card Payment received re [522] Notice of Appeal (Federal Circuit) filed by Wyeth LLC. ( Filing fee $605, receipt number ADEDC-4497024.) (Dellinger, Megan) (Entered: 09/12/2024) | |
| 09/12/24 | Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [522] Notice of Appeal (Federal Circuit). (mpb) (Entered: 09/12/2024) | |
| 09/04/24 | OBJECTIONS by Wyeth LLC to [519] Bill of Costs . (Dellinger, Megan) (Entered: 09/04/2024) | |
| 09/03/24 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Dexcel and Aurobindo's First Set of Common Requests for the Production of Documents and Things (Nos. 1-7) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 09/03/2024) | |
| 09/03/24 | NOTICE OF SERVICE of Plaintiffs' Supplemental Disclosure of Asserted Claims and Infringement Contentions for Zenara's ANDA Product filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 09/03/2024) | |
| 08/29/24 | Pro Hac Vice Attorney Emer L. Simic for Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 08/29/2024) | |
| 08/26/24 | SO ORDERED, D.I. [99] Amended Stipulation and Order Further Amending the Scheduling Order filed by Zenara Pharma Private Limited. Ordered by Judge Christopher J. Burke on 8/26/2024. (mpb) Modified on 8/26/2024 (smg). (Entered: 08/26/2024) | |
| 08/21/24 | DECLARATION re 519 Bill of Costs [Declaration of Melissa Keech in Support of AstraZeneca's Bill of Costs] by AstraZeneca AB, AstraZeneca PLC, AstraZeneca Pharmaceuticals, LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(DiBenedetto, Emily) (Entered: 08/21/2024) | |
| 08/21/24 | BILL OF COSTS by AstraZeneca AB, AstraZeneca Pharmaceuticals, LP. (DiBenedetto, Emily) (Entered: 08/21/2024) |